Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children &lt;5 Years of Age, 2009–2011

C. Payne, Daniel; A. Boom, Julie; Allen Staat, Mary; M. Edwards, Kathryn; G. Szilagyi, Peter; J. Klein, Eileen; Selvarangan, Rangaraj; H. Azimi, Parvin; Harrison, Christopher; E. Moffatt, Mary; H. Johnston, Samantha; C. Sahni, Leila; J. Baker, Carol; A. Rench, Marcia; Donauer, Stephanie; McNeal, Monica; D. Chappell, James; A. Weinberg, Geoffrey; Tasslimi, Azadeh; E. Tate, Jacqueline; E. Wikswo, Mary; T. Curns, Aaron; Sulemana, Iddrisu; Mijatovic-Rustempasic, Slavica; D. Esona, Mathew; D. Bowen, Michael; R. Gentsch, Jon; D. Parashar, Umesh

doi:10.1093/cid/cit164

Public

Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009–2011

Published in Clinical Infectious Diseases • Mar 13, 2013

Authors:

Daniel C. Payne

Julie A. Boom

Mary Allen Staat

Abstract

BACKGROUND: We assessed vaccine effectiveness (VE) for RotaTeq (RV5; 3 doses) and Rotarix (RV1; 2 doses) at reducing rotavirus acute gastroenteritis (AGE) inpatient and emergency department (ED) visits in US children. METHODS: We enrolled children <5 years of age hospitalized or visiting the ED with...

Subject

Rotavirus

Medicine

Rotavirus vaccine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!